ICI Pharmaceuticals Group
Executive Summary
Timothy Gau, MD, promoted to VP-clinical and medical affairs. Gau joined ICI in 1984 and was responsible for the development of Nolvadex (tamoxifen). Robert Black returns to U.S. as VP-sales and marketing from 18-month stint at U.K. headquarters.